Editas Medicine, Inc. (EDIT)

Last Closing Price: 5.62 (2024-05-17)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Editas Medicine, Inc. (EDIT) had Net Income of $-153.22M for the most recently reported fiscal year, ending 2023-12-31.

Figures for fiscal year ending 2023-12-31
Income Statement Financials
$78.12M
Net Income
$-153.22M
--
$78.12M
$247.30M
$-169.18M
$15.96M
$-153.22M
$-153.22M
$-153.22M
$-153.22M
$-153.22M
$-153.22M
$-169.18M
$-167.94M
75.97M
75.97M
$-2.02
$-2.02
Balance Sheet Financials
$340.83M
$12.03M
$158.32M
$499.15M
$63.22M
--
$86.84M
$150.06M
$349.10M
$349.10M
$349.10M
81.77M
Cash Flow Statement Financials
$-132.18M
$-3.73M
$118.04M
$145.40M
$127.53M
$-17.87M
$19.80M
--
--
Fundamental Metrics & Ratios
5.39
--
--
--
--
100.00%
-216.56%
-216.56%
-214.97%
-196.13%
-196.13%
$-136.90M
--
--
--
0.16
--
7.67
47.59
-43.89%
-43.89%
-30.70%
-43.89%
$4.27
$-1.80
$-1.74